Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome.
BACKGROUND: Chronic fatigue syndrome (CFS) has no diagnostic clinical signs or diagnostic laboratory abnormalities and it is unclear if it represents a single illness. The CFS research case definition recommends stratifying subjects by co-morbid conditions, fatigue level and duration, or functional impairment. But to date, this analysis approach has not yielded any further insight into CFS pathogenesis. This study used the integration of peripheral blood gene expression results with epidemiologic and clinical data to determine whether CFS is a single or heterogeneous illness. RESULTS: CFS subjects were grouped by several clinical and epidemiological variables thought to be important in defining the illness. Statistical tests and cluster analysis were used to distinguish CFS subjects and identify differentially expressed genes. These genes were identified only when CFS subjects were grouped according to illness onset and the majority of genes were involved in pathways of purine and pyrimidine metabolism, glycolysis, oxidative phosphorylation, and glucose metabolism. CONCLUSION: These results provide a physiologic basis that suggests CFS is a heterogeneous illness. The differentially expressed genes imply fundamental metabolic perturbations that will be further investigated and illustrates the power of microarray technology for furthering our understanding CFS.
Whistler
Toni
T
Viral Exanthems and Herpes Virus Branch, Division of Viral and Rickettsial Diseases, National Centre for Infectious Diseases, Centres for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, Georgia. sdv2@cdc.gov
Unger
Elizabeth R
ER
Nisenbaum
Rosane
R
Vernon
Suzanne D
SD